IHM
SLDB icon

Iguana Healthcare Management’s Solid Biosciences SLDB Stock Holding History

Iguana Healthcare Management’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$375K Buy
+3,333
New +$1.13M 0.25% 62

Other funds holding SLDB

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Iguana Healthcare Management's SLDB Position: Q1 2018 in Review

Iguana Healthcare Management opened a new position in Solid Biosciences (SLDB) in Q1 2018: 3,333 shares worth $375K. The stake represents 0.25% of the portfolio and ranks #62 among its holdings.

58 funds tracked by Wall St. Rank hold SLDB as of Q1 2018.

  • Iguana Healthcare Management held 3,333 shares of Solid Biosciences worth $375K as of Q1 2018.
  • Solid Biosciences was a new Iguana Healthcare Management position in Q1 2018.
  • Solid Biosciences made up 0.25% of Iguana Healthcare Management's portfolio in Q1 2018, its #62 holding.
  • 58 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.